Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Caming Pharmaceutical Ltd, a member of the FCAD Group, is a global pharmaceutical chemical company specializing in the development and manufacture of Active Pharmaceutical Ingredients (APIs), pharmaceutical intermediates, impurities, and diagnostic reagents. Founded in 2002 and headquartered in London with significant operations in China, the company serves as a strategic partner to major global pharmaceutical firms such as Pfizer, Merck, and AstraZeneca. Caming focuses on providing high-quality chemical solutions and custom synthesis services to accelerate drug development timelines, explicitly stating that it does not develop "final medicines" itself. Its diverse portfolio includes products for oncology, immunology, and cardiovascular health, as well as specialized tools like COVID-19 rapid test devices and veterinary compounds.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Caming Pharmaceutical.